Cetilistat is a gastrointestinal lipase inhibitor designed for the treatment of obesity, functioning through a mechanism analogous to orlistat by preventing the absorption of dietary triglycerides in the… Read more













Cetilistat is a gastrointestinal lipase inhibitor designed for the treatment of obesity, functioning through a mechanism analogous to orlistat by preventing the absorption of dietary triglycerides in the intestine. To support the rigorous demands of pharmaceutical analysis, this category provides a comprehensive selection of reference standards, including the parent Cetilistat API, as well as critical pharmacopeial and non-pharmacopeial impurities. Laboratories require these high-quality materials for impurity profiling, method development, and the validation of analytical procedures to ensure regulatory compliance and product safety. By utilizing these precisely characterized compounds, researchers and quality control scientists can accurately identify and quantify degradation products and synthetic by-products throughout the drug development lifecycle. The inclusion of stable isotope labelled compounds further facilitates precise mass spectrometry-based quantification, ensuring robust and reliable results in complex biological and pharmaceutical matrices.